Jolanda Howe - Jul 1, 2024 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
SVP, GLOBAL CONTROLLER
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Jul 1, 2024
Transactions value $
-$12,750
Form type
4
Date filed
7/3/2024, 06:19 PM
Previous filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Options Exercise +1.04K +59.24% 2.8K Jul 1, 2024 Direct F1
transaction MIRM Common Stock Sale -$12.8K -375 -13.39% $34.00 2.43K Jul 2, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Restricted Stock Units Options Exercise $0 -1.04K -50.02% $0.00 1.04K Jul 1, 2024 Common Stock 1.04K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
F2 Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
F3 The restricted stock units vest in a series of three successive equal annual installments beginning July 1, 2023.